3,625
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 1592-1604 | Received 05 Mar 2021, Accepted 22 Oct 2021, Published online: 22 Nov 2021

References

  • Acevedo-Duncan M, Russell C, Patel S, Patel R. 2004. Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells. Int Immunopharmacol. 4(14):1775–1784.
  • Cai FF, Bian YQ, Wu R, Sun Y, Chen XL, Yang MD, Zhang QR, Hu Y, Sun MY, Su SB. 2019. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother. 114:108863–108872.
  • Chen M, Theander TG, Christensen SB, Hviid L, Zhai L, Kharazmi A. 1994. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother. 38(7):1470–1475.
  • Dao TT, Nguyen PH, Lee HS, Kim E, Park J, Lim SI, Oh WK. 2011. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett. 21(1):294–298.
  • Dong S, Cai FF, Chen QL, Song YN, Sun Y, Wei B, Li XY, Hu YY, Liu P, Su SB. 2018. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacol Sin. 39(6):930–941.
  • Dong S, Su SB. 2014. Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis. J Integr Med. 12(3):147–155.
  • Eloundou-Mbebi JM, Kuken A, Omranian N, Kleessen S, Neigenfind J, Basler G, Nikoloski Z. 2016. A network property necessary for concentration robustness. Nat Commun. 7:13255–13261.
  • Eng FJ, Friedman SL. 2000. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol. 279(1):G7–G11.
  • Friis-Moller A, Chen M, Fuursted K, Christensen SB, Kharazmi A. 2002. In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med. 68(5):416–419.
  • Fu Y, Hsieh TC, Guo J, Kunicki J, Lee MY, Darzynkiewicz Z, Wu JM. 2004. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun. 322(1):263–270.
  • Geerts A. 2001. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 21(3):311–335.
  • Guo J, Xiao B, Zhang S, Liu D, Liao Y, Sun Q. 2007. Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin. Cancer Biol Ther. 6(1):85–88.
  • Han Y, Li H, Lang Y, Zhao Y, Sun H, Zhang P, Ma X, Han J, Wang Q, Zhou J, et al. 2017. The effects of acute GABA treatment on the functional connectivity and network topology of cortical cultures. Neurochem Res. 42(5):1394–1402.
  • Hao Y, Zhang C, Sun Y, Xu H. 2019. Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma. Onco Targets Ther. 12:4427–4435.
  • Harvey RA, Hayden JD, Kamble PS, Bouchard JR, Huang JC. 2017. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example. Pharmacoepidemiol Drug Saf. 26(4):368–377.
  • Hernandez-Aquino E, Zarco N, Casas-Grajales S, Ramos-Tovar E, Flores-Beltran RE, Arauz J, Shibayama M, Favari L, Tsutsumi V, Segovia J, et al. 2017. Naringenin prevents experimental liver fibrosis by blocking TGFbeta-Smad3 and JNK-Smad3 pathways. WJG. 23(24):4354–4368.
  • Hernandez-Gea V, Friedman SL. 2011. Pathogenesis of liver fibrosis. In: Abbas AK, Galli SJ, Howley PM, editors. Annual review of pathology: mechanisms of disease. New York (NY): Annual Reviews; p. 425–456.
  • Higashi T, Friedman SL, Hoshida Y. 2017. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 121:27–42.
  • Hong SH, Cha HJ, Hwang-Bo H, Kim MY, Kim SY, Ji SY, Cheong J, Park C, Lee H, Kim GY, et al. 2019. Anti-proliferative and pro-apoptotic effects of licochalcone a through ROS-mediated cell cycle arrest and apoptosis in human bladder cancer cells. Int J Mol Sci. 20(15):3820–3835.
  • Kim WS, Song HY, Han JM, Byun EB. 2019. GLM, a novel luteolin derivative, attenuates inflammatory responses in dendritic cells: therapeutic potential against ulcerative colitis. Biochem Biophys Res Commun. 518(1):87–93.
  • Kong X, Horiguchi N, Mori M, Gao B. 2012. Cytokines and STATs in liver fibrosis. Front Physiol. 3:69–75.
  • Koyama Y, Brenner DA. 2015. New therapies for hepatic fibrosis. Clin and Res Hepatol Gastroenterol. 39:S75–S79.
  • Lakner AM, Moore CC, Gulledge AA, Schrum LW. 2010. Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation. World J Gastroenterol. 16(40):5047–5056.
  • Li XJ, Ma QY, Jiang YM, Bai XH, Yan ZY, Liu Q, Pan QX, Liu YY, Chen JX. 2017. Xiaoyaosan exerts anxiolytic-like effects by down-regulating the TNF-α/JAK2-STAT3 pathway in the rat hippocampus. Sci Rep. 7(1):353–365.
  • Liu C, Hu Y, Xu L, Liu C, Liu P. 2009. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 4:12–22.
  • Liu K, Park C, Li S, Lee KW, Liu H, He L, Soung NK, Ahn JS, Bode AM, Dong Z, et al. 2012. Aloe-emodin suppresses prostate cancer by targeting the mTOR complex 2. Carcinogenesis. 33(7):1406–1411.
  • Liu Y, Wang M, Luo Y, Chen C, Lu Y, Shi Y, Tang C, Zhou Q, Zhang H, Hu Y, et al. 2017. miRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis. Sci Rep. 7(1):11054–11065.
  • Liu L, Yang J, Zu B, Wang J, Sheng K, Zhao L, Xu W. 2018. Acacetin regulated the reciprocal differentiation of Th17 cells and Treg cells and mitigated the symptoms of collagen-induced arthritis in mice. Scand J Immunol. 88(4):e12712.
  • Liver Disease Committee. 2019. Guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional Chinese and Western medicine (2019 edition). Chinese J Hepatol. 27:494–504. Chinese.
  • Lopez-Lazaro M. 2009. Distribution and biological activities of the flavonoid luteolin. MRMC. 9(1):31–59.
  • Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem. 67:753–791.
  • Park SJ, Sohn HY, Yoon J, Park SI. 2009. Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells. Cell Signal. 21(10):1495–1503.
  • Parvez MK, Al-Dosari MS, Alam P, Rehman M, Alajmi MF, Alqahtani AS. 2019. The anti-hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera. Phytother Res. 33(11):2960–2970.
  • Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. 2009. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 10(8):717–742.
  • Seki E, Schwabe RF. 2015. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 61(3):1066–1079.
  • Shi SH, Cai YP, Cai XJ, Zheng XY, Cao DS, Ye FQ, Xiang Z. 2014. A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease. PLoS One. 9(3):e89123.
  • Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N. 1998. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett. 438(3):220–224.
  • Song YN, Zhang GB, Lu YY, Chen QL, Yang L, Wang ZT, Liu P, Su SB. 2016. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: an analysis of bile acids metabolic mechanism. J Ethnopharmacol. 189:148–156.
  • Su SB, Jia W, Lu A, Li S. 2014. Evidence-based ZHENG: a traditional Chinese medicine syndrome 2013. Evid Based Complement Alternat Med. 2014:484201–484202.
  • Tang LY, Heller M, Meng Z, Yu LR, Tang Y, Zhou M, Zhang YE. 2017. Transforming growth factor-β (TGF-β) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem. 292(10):4302–4312.
  • Tang Y, Liao Y, Kawaguchi-Sakita N, Raut V, Fakhrejahani E, Qian N, Toi M. 2011. Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats. J Hepatobiliary Pancreat Sci. 18(4):551–558.
  • Tian JS, Peng GJ, Wu YF, Zhou JJ, Xiang H, Gao XX, Zhou YZ, Qin XM, Du GH. 2016. A GC-MS urinary quantitative metabolomics analysis in depressed patients treated with TCM formula of Xiaoyaosan. J Chromatogr B Analyt Technol Biomed Life Sci. 1026:227–235.
  • Tsuchida T, Friedman SL. 2017. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 14(7):397–411.
  • Wieczorek J, Malik-Sheriff RS, Fermin Y, Grecco HE, Zamir E, Ickstadt K. 2015. Uncovering distinct protein-network topologies in heterogeneous cell populations. BMC Syst Biol. 9:24–35.
  • Wu WY, Li YD, Cui YK, Wu C, Hong YX, Li G, Wu Y, Jie LJ, Wang Y, Li GR. 2018. The natural flavone acacetin confers cardiomyocyte protection against hypoxia/reoxygenation injury via ampk-mediated activation of nrf2 signaling pathway. Front Pharmacol. 9:497–512.
  • Xiao D, Zhang Y, Wang R, Fu Y, Zhou T, Diao H, Wang Z, Lin Y, Li Z, Wen L, et al. 2019. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharm Sin B. 9(4):724–733.
  • Yan Y, Jun C, Lu Y, Jiangmei S. 2019. Combination of metformin and luteolin synergistically protects carbon tetrachloride-induced hepatotoxicity: mechanism involves antioxidant, anti-inflammatory, antiapoptotic, and Nrf2/HO-1 signaling pathway. Biofactors. 45(4):598–606.
  • Yoon YJ, Friedman SL, Lee YA. 2016. Antifibrotic therapies: where are we now? Semin Liver Dis. 36(1):87–98.
  • Zhang L, Schuppan D. 2014. Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype. J Hepatol. 61(1):166–168.
  • Zhou Y, Wu R, Cai F-F, Zhou W-J, Lu Y-Y, Zhang H, Chen Q-L, Su S-B. 2021. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis. J Ethnopharmacol. 264:113021–113033.